Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

clinical trials

This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.

UK is a leader in early clinical research but falls in later study stages, says ABPI

UK is a leader in early clinical research but falls in later study stages, says ABPI

The findings come from the ABPI’ s first annual report into clinical trials, and demonstrated the strengths and weaknesses of the UK’s clinical research sector. ... This includes increased investment into clinical research, simplifying the processes

Latest news

More from news
Approximately 162 fully matching, plus 1,642 partially matching documents found.

Latest Intelligence

  • Rethinking trials: the pros and cons of protocol amendments Rethinking trials: the pros and cons of protocol amendments

    Late phase clinical trials are more complex and involve more patients, which makes amendments – including relating to patient safety – more likely, Learn continued. ... The European Medicines Agency is not responsible for approving or overseeing the

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    In fact, according to a recent report, there were 1, 028 clinical trials for regenerative therapies taking place globally at the end of 2018. ... As such, information about supply chain management needs to be submitted to the regulator after the

  • Integrating patient reported outcomes into clinical trials Integrating patient reported outcomes into clinical trials

    useable. Designing PRO protocols. The choice of measure is just one of the critical decisions sponsors face when integrating PROs into their clinical trials. ... At a time when quality-of-life measures are driving commercial outcomes, sponsors’ ability

  • Mastering data protection in the pharma industry Mastering data protection in the pharma industry

    GDPR and the Clinical Trials Regulation (CTR) (which entered into force in 2014 and is expected to become applicable in 2020). ... The CTR’s objective is to harmonise the rules for conducting clinical trials throughout the EU.

  • Encouraging signs in biomarker R&D Encouraging signs in biomarker R&D

    The timing of the withdrawal was ironic given that, in the same month, FDA Commissioner Scott Gottlieb highlighted ‘TMB as a potential biomarker for enriching clinical trials testing immunotherapies’. ... Clinical evolution. Greater use of biomarkers

More from intelligence
Approximately 12 fully matching, plus 165 partially matching documents found.

Latest appointments

  • New hires at Bayer, Eisai and Accord Healthcare New hires at Bayer, Eisai and Accord Healthcare

    She joins Eisai from Merck, where she served as executive director, clinical quality assurance, head of global GCP for infectious disease and vaccines. ... In that role, Chaturvedi oversaw the end-to-end quality assurance for a large portfolio of

  • New hires at Nanoform, Leo Pharma and Calliditas New hires at Nanoform, Leo Pharma and Calliditas

    and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics.

  • Zelluna Immunotherapy appoints chief technology officer Zelluna Immunotherapy appoints chief technology officer

    His experience, acquired on both side’s of the Atlantic will provide invaluable for Zelluna in its immediate focus of delivering clinical proof of concept of its TCRs in adoptive cell ... He will play a big part in the execution of Zelluna’s

  • Neurocentrx appoints two members to the board Neurocentrx appoints two members to the board

    Brooksby said: “My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market.

  • Life Healthcare appoints two new starters Life Healthcare appoints two new starters

    Joining Alisha is Caitlin McMaster (pictured right), who takes up an account executive role at Life Healthcare, working alongside the clinical trials team.

More from appointments
Approximately 0 fully matching, plus 62 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 18 fully matching, plus 87 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Quick links

Infographics

Multimedia